Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.8080
-2.4720 (-75.37%)
Jul 3, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 107.9 million as of July 2, 2026. Its market cap has decreased by -78.17% in one year.
Market Cap
107.90M
Enterprise Value
74.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.81
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 107.90M, a decrease of -80.81%. That is a compound annual growth rate of -20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 107.90M | -73.55% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 148.41M |
| NextCell Pharma AB | 122.60M |
| Simris Group AB (PUBL) | 120.94M |
| Alligator Bioscience AB | 108.79M |
| Biovica International AB | 108.01M |
| OncoZenge AB | 102.41M |
| Scandinavian ChemoTech AB | 95.45M |
| Spago Nanomedical AB | 93.81M |